A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.
Almitrine has been studied across 16 research domains including 🫁 Respiratory, 🧘 Stress & Anxiety, ❤️ Cardiovascular, 😴 Sleep, 🧠 Focus & Attention. The primary research focus is 🫁 Respiratory with 62% of studies addressing this area.
This evidence profile for Almitrine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.